Inflation Pressures Widen Beyond Oil and Iran Housing Food and Services Show Price Acceleration Amazon Reports Record Thanksgiving Holiday Week Sales and Items Sold JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook GitHubs AI Coding Dominance Stalled by Outages and New Rivals SpaceX IPO Sector Classification Balancing Rockets Satellites and AI in SP Index SpaceX Scrubs Starship Test Flight Aims for Friday Launch Amid Ambitious Space Goals THRY Q1 2026 Earnings Massive EPS Beat Lifts Shares as Expense Discipline Shines GANX Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction HRMY Q1 2026 Earnings EPS Misses Estimates Stock Dips AEBI Q1 2026 Earnings Earnings Per Share Misses Estimates Stock Edges Higher SCHL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Response Crown Crafts Inc CRWS Q1 2026 Earnings Earnings Beat With EPS of 014 Despite Sparse Disclosures Johnson Johnson JNJ Edges Higher as Defensive Appeal Strengthens Heidmar Maritime Holdings Corp HMR Surges Over 29 in a Robust Trading Session Quantumsphere Acquisition Corp QUMS Holds Steady at 1019 as Support and Resistance Levels Come into Focus TPGXL 6950 Junior Subordinated Notes Holds Steady Near Support as Yield Attracts Income Seekers Liminatus Pharma LIMN Plunges 31 as Support Level Approaches Key Levels to Watch Trump Seeks Supreme Court Intervention to Delay TikTok Ban What It Means for Markets BX Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline Starfighters Space Inc FJET Maintains Uptrend Resistance at 701 in Focus PennantPark Floating Rate Capital PFLT Edges Higher Amid Stable Trading Volume Lite Strategy Inc LITS Slides 273 as Selling Pressure Mounts Near Key Support ZKH Group Limited ZKH Edges Higher as Stock Tests Key Resistance BOS Better Online Solutions BOSC Edges Higher Consolidating Near Key Resistance Farmer Brothers FARM Holds Steady at 128 as Trading Remains Rangebound AIM ImmunoTech AIM Slides 26 to 024 as Bearish Pressure Persists Cue Biopharma CUE Shows Modest Gain as Biotech Sector Watches Key Levels